Oznámenie o prvom uvedení, prerušení, obnovení alebo zrušení dodávok humánneho lieku
 PodanieDržiteľKódLiekÚčinnosť ▲Predmet
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40668THERACAP 131 TM (cps 1x1998 MBq (púzdro))31.12.2024Z
 23.7.2024Zentiva, k.s. (ZNT-1)34743Rispen 2 (tbl flm 20x2 mg (blis.PVC/PVDC/Al))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40636THERACAP 131 TM (cps 1x851 MBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40676THERACAP 131 TM (cps 1x3,330 GBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)46503THERACAP 131 TM (cps 1x37 MBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40686THERACAP 131 TM (cps 1x5,365 GBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)66466THERACAP 131 TM (cps 1x3,7 GBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40678THERACAP 131 TM (cps 1x3,885 GBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40667THERACAP 131 TM (cps 1x1961 MBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40670THERACAP 131 TM (cps 1x2,220 GBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40644THERACAP 131 TM (cps 1x1147 MBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40625THERACAP 131 TM (cps 1x481 MBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40674THERACAP 131 TM (cps 1x2,960 GBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40679THERACAP 131 TM (cps 1x4,070 GBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40648THERACAP 131 TM (cps 1x1295 MBq (púzdro))31.12.2024Z

Predmet vo význame:
U-Prvé uvedenie liekov na slovenský trh, R-Prerušenie dodávania liekov na slovenský trh,
O-Obnovenie dodávania liekov na slovenský trh, Z-Zrušenie dodávania liekov na slovenský trh


Účinnosť
Od
Do